Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours
- PMID: 2857420
- DOI: 10.1016/s0140-6736(85)91386-8
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours
Abstract
The presence of epidermal-growth-factor (EGF) receptors in normal and neoplastic human urothelium was studied in 12 control patients and in 48 patients with transitional cell carcinoma of the bladder, 24 with invasive (pT3) and 24 with superficial tumours (9 pT1, 15 pTa). EGF receptors were identified on frozen sections by means of an indirect immunoperoxidase technique with a monoclonal antibody against the EGF receptor. Significantly more invasive tumours (21 of 24) than superficial (7 of 24) were stained positively for the EGF receptor (X2 = 14.49; p less than 0.001). Significantly more poorly differentiated tumours (18 of 21) than moderately differentiated tumours (10 of 27) were EGF-receptor positive (X2 = 9.6; p less than 0.01). No control sample stained positively for the EGF receptor. These findings suggest that the presence of a high intensity of staining for the EGF receptor in human bladder tumours is associated with poor differentiation and with invasion.
Similar articles
-
Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.Cancer Res. 1990 Apr 15;50(8):2530-7. Cancer Res. 1990. PMID: 1690599
-
Histochemical study of lectin binding in neoplastic and non-neoplastic urothelium.Br J Urol. 1987 Nov;60(5):399-404. doi: 10.1111/j.1464-410x.1987.tb05002.x. Br J Urol. 1987. PMID: 3322471
-
Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.Urol Oncol. 2004 Mar-Apr;22(2):93-101. doi: 10.1016/j.urolonc.2004.01.001. Urol Oncol. 2004. PMID: 15082004
-
Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.Dan Med Bull. 1994 Feb;41(1):1-11. Dan Med Bull. 1994. PMID: 8187557 Review.
-
Epidermal growth factor and its receptor: markers of--and targets for--chemoprevention of bladder cancer.J Cell Biochem Suppl. 1992;16I:56-62. doi: 10.1002/jcb.240501312. J Cell Biochem Suppl. 1992. PMID: 1305689 Review.
Cited by
-
Epidermal growth factor prolongs survival time of tumor-bearing mice.Jpn J Cancer Res. 1990 May;81(5):495-500. doi: 10.1111/j.1349-7006.1990.tb02597.x. Jpn J Cancer Res. 1990. PMID: 2116398 Free PMC article.
-
Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture.Acta Neuropathol. 1992;84(2):190-7. doi: 10.1007/BF00311394. Acta Neuropathol. 1992. PMID: 1523973
-
In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals.Clin Exp Metastasis. 1995 Nov;13(6):407-19. doi: 10.1007/BF00118180. Clin Exp Metastasis. 1995. PMID: 7586799
-
Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines.Urol Res. 1993 Jan;21(1):27-32. doi: 10.1007/BF00295188. Urol Res. 1993. PMID: 8456535
-
Intraluminal epidermal growth factor affects growth of N-methyl-N-nitrosourea-initiated rat bladder carcinoma.Jpn J Cancer Res. 1995 May;86(5):429-34. doi: 10.1111/j.1349-7006.1995.tb03075.x. Jpn J Cancer Res. 1995. PMID: 7790316 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical